Published Studies on the Efficacy of MSM (methylsulfonylmethane)

Document technical information

Format pdf
Size 268.1 kB
First found May 22, 2018

Document content analysis

Category Also themed
Language
English
Type
not defined
Concepts
no text concepts found

Persons

Organizations

Places

Transcript

Published Studies on the Efficacy of MSM
(methylsulfonylmethane)
Skin Studies
Skin Studies-Human
Anthonavage, M. et al. 2015
Natural Medicine Journa
l
Study using
OptiMSM ®
Study Title
Effects of Oral
Supplementation With
Methylsulfonylmethane
on Skin Health and Wrinkle
Reduction
Study Summary
Two-part study. Part one was a pre-clinical evaluation of gene
expression in a 3D skin model. Results supported the design of
clinical portion. Part two was a double-blind placebo controlled
design. 20 healthy females randomized to take 3g MSM per
day or placebo for 16 weeks. Significant improvements in skin
appearance and condition were found in the treatment group
when evaluated by expert grading, instrumental analysis, and
participant self-assessment.
Exercise Recovery Studies
Exercise Recovery
Studies-Human
Study Title
van der Merwe, M. et al. 2016
The Influence of
Methylsulfonylmethane on
Inflammation-Associated
Cytokine Release before
and following Streneous
Exercise.”
Double-blind, placebo controlled study. 40 healthy, resistance
trained males received 3g MSM or placebo for 28 days before
eccentric knee exercise. In-vivo cytokine analysis was performed
before and through 72 hours post-exercise. Additional cytokine
analysis was performed in-vitro and ex-vivo on whole blood
and isolated single blood cells from a subset of subjects, with
and without LPS stimulation. Results indicate MSM dampens
inflammatory expression following exercise and reduces postexercise immunosuppression.
The Effects of MSM
Supplementation on Knee
Kinetics during Running,
Muscle Strength, and
Muscle Soreness following
Eccentric Exercise- Induced
Quadriceps Damage
Double-blind, placebo controlled study. 40 healthy resistancetrained men; 3 g/day for 28 days before eccentric knee exercise.
Testing occurred before exercise (Baseline) then at 0hr, 24hrs,
48hrs and 72 hrs post exercise. @ 72 hrs Maximum Isometric
Force (MIF) normal in MSM group but still 8% below BL for
Placebo. Absolute change in muscle soreness during passive
knee flexion was smaller in MSM group. Some findings of this
study suggest individuals may be able to return to regular
training more quickly following knee extensor damage with MSM
supplementation.
Effects of MSM on
exercise-induced muscle
and joint pain: a pilot
study
Double-blind, placebo controlled study design. 22 healthy adults
randomly assigned to take either 3g of MSM per day or placebo
for 21 days before running a half marathon. MSM attenuated
post-exercise induced muscle and joint pain at clinically significant
levels compared to placebo. Statistically significance was not
reached possibly due to small sample size
A Randomized Double
Blind Placebo Controlled
Evaluation of MSM
for Exercise Induced
Discomfort/Pain
Double-blind, placebo controlled study. 24 healthy adult males
randomly assigned to receive either treatment or placebo for 14
days. Intervention of 3 grams of MSM per day for the 14 day period
resulted in significantly lower (1.55 + 0.82 vs. 3.75 + 2.58 p=0.012)
pain/discomfort 2 hours following a leg extension exercise to
muscle failure when compared to the placebo group.
Journal of Sports Medicine, vol
2016, Article ID 7498359
Study using
OptiMSM ®
Peel S. et al. 2015
Presented at American
Society for Biomechanics
Conference Aug, 2015 At
Columbus, OH
Published abstract and
poster presentation
Study Summary
Study using
OptiMSM ®
Withee. et al. 2015
Journal of the International
Society of Sports Nutrition
Published abstract and poster
presentation
Study using
OptiMSM ®
Kalman D. et al. 2013
FASEB J, 2013, 27:1076.7
Published abstract and poster
presentation
Study using
OptiMSM ®
This paper is intended to provide scientific and educational information only. It is not intended for use to promote or sell any
product. These statements have not been evaluated by the Food and Drug Administration. Consumption of OptiMSM ® is not
intended for use to diagnose, treat, cure or prevent any disease.
OptiMSM ® is manufactured by Bergstrom Nutrition. ©2016 Bergstrom Nutrition. All rights reserved. Ver 1.0 06/15/2016
1
Published Studies on the Efficacy of MSM
(methylsulfonylmethane)
Nakhostin-Roohi B. 2013
Iranian J of Pharma Research
2013,
12(4): 845-853
Barmaki, S. et al. 2012
J. Sports Med Phys Fitness
2012;52:170-4
Kalman D. et al. 2012
J. of Int. Society of Sports Nut.
2012, 9:46
Study using
OptiMSM ®
Nakhostin-Roohi et al.2011
Journal of Pharmacy and
Pharmacology
2011, 63:1290-1294
Exercise Studies-Animal
Marañón et al. 2006
Acta Veterinaria Scandinavica
2008;
50:45 doi:10.1186/1751-014750-45
Effect of Single Dose
Administration of
Methylsulfonylmethane
on Oxidative Stress
Following Acute
Exhaustive Exercise
16 subjects randomly assigned to receive either 100mg/kg BW
(6g for a 60kg person) MSM in water or placebo (just water) were
subjected to treadmill running until exhaustion. Protein Carbonyls
were lower at 2, and 24 hrs post exercise. Plasma TAC was higher
at 24 hrs after exercise. Serum levels of bilirubin and uric acid were
significantly lower immediately after exercise in the MSM group.
Results suggest a single oral dose of MSM lowers exercise induced
oxidative stress in healthy untrained men, but is not adequate to
significantly affect reduced glutathione levels.
Effect of MSM
Supplementation on
Exercise-induced Muscle
Damage and Total
Antioxidant Capacity
Double-blind, placebo controlled study. 18 subjects; treatment
= 50mg/kg BW/day MSM for 10 days before a 14 km run. CK and
Bilirubin was significantly reduced in MSM group vs. placebo.
TAC significantly increased. MSM decreased muscle damage via
antioxidant capacity.
Influence of MSM on
Markers of Exercise
Recovery and
Performance and Total
Antioxidant Capacity
8 subjects were randomly assigned either 1.5 or 3.0g of MSM
per day for 30 days. Leg extension exercise to exhaustion. TEAC
increased in a dose-dependant manner. Fatigue and homocysteine
decreased in dose dependant manner. MSM may favorably
influence selected markers of exercise recovery, especially at 3g/
day.
Effect of Chronic
Supplementation with
MSM on Oxidative Stress
Following Acute Exercise in
Untrained Healthy Men
Double-blind, placebo controlled study. 18 subjects; treatment
= 50mg/kg BW/day MSM for 10 days before a 14 km run. Serum
MDA, PC, GSSG, GSH, and GSH/GSSG ratio were evaluated. MDA,
PC, GSSG were significantly reduced in treatment group vs. placebo
and GSH and ratio were increased. MSM decreased oxidative stress
following acute exercise.
Study Title
Study Summary
The Effect of MSM
Supplementation on
Biomarkers of Oxidative
Stress in Sport Horses
Following Jumping
Exercise
Study using
OptiMSM ®
Joint Support StudiesHuman
Pagonis et al. 2014
Int Journal of Orthopaedics
2014 June 23 1(1): 19-24
ISSN2311-5106
Debbi et al. 2011
BMC Comp and Alt Med 2011,
11:50
24 jumping horses divided into 3 groups; control, [email protected] 8 mg/kg
BW and comboof 8mg/kg MSM and Vit C 5mg/kg. Blood samples
collected before and after exercise.NO, CO, Lipid Hydroperoxides,
and Antioxidant enzymes, glutathione peroxidase,glutathione
transferase and glutathione reductase measured. Exercise induced
significantincrease in lipid peroxidation, NO, and CO. Reduced
glutathione, and antioxidantenzyme activity was decreased. MSM
significantly ameliorated all of these exercise-related changes and
the combo of MSM/Vit C potentiated this effect with some ofthe
parameters close to pre-exercise levels.
Study Title
Study Summary
The Effect of
Methylsulfonylmethane on
Osteoarthritic Large Joints
and Mobility
Double-blind, placebo controlled study. 100 subjects took MSM 3g
twice daily for 26 wks. Statistically significant improvement for MSM
group in all WOMAC and SF-36 quality of life scores. No adverse
effects reported.
Efficacy of
Methylsulfonylmethane
Supplementation on
Osteoarthritis of the Knee:
A Randomized Controlled
Study
Double-blind, 49 subjects, 12 week treatment with 1.125 g of
MSM 3X daily. Significant improvement seen in pain and physical
function. WOMAC, VAS, KSKS, ALF scales utilized.
This paper is intended to provide scientific and educational information only. It is not intended for use to promote or sell any
product. These statements have not been evaluated by the Food and Drug Administration. Consumption of OptiMSM ® is not
intended for use to diagnose, treat, cure or prevent any disease.
OptiMSM ® is manufactured by Bergstrom Nutrition. ©2016 Bergstrom Nutrition. All rights reserved. Ver 1.0 06/15/2016
2
Published Studies on the Efficacy of MSM
(methylsulfonylmethane)
Kim et al. 2006
OsteoArthritis and Cartilage
2006, 14:286-294
Usha and Naidu. 2004
Clin Drug Invest 2004, 24:6
353-363
Efficacy of MSM in
Osteoarthritis Pain of the
Knee: A Pilot Clinical Trial
Double-blind, placebo controlled study. 50 subjects MSM 3g twice
daily for 12 wks. Significant reduction for MSM group in WOMAC
pain, Urine MDA and Plasma Homocysteine. SF-36 scores indicated
improvement in basic performing activities in the treatment group.
Randomized, DoubleBlind, Parallel, PlaceboControlled Study of
Oral Glucosamine,
Methylsulfonylmethane
and their Combination in
Osteoarthritis
118 patients randomized to receive placebo, 500mg Glu, 500mg
MSM, or combo of 500mg Glu + 500mg MSM for 12 wks. Glu, MSM
and their combination produced analgesic and anti-inflammatory
effect. VAS, Lesquene index and consumption of rescue meds
measured.
Joint Support Studies
Joint Support StudiesAnimal
Ezaki et al. 2012
J Bone Miner Metab. 2013
Jan;31(1):16-25. doi: 10.1007/
s00774-012-0378-9. Epub
2012 Aug 10.
Hasegawa T, Ueno S,
Kumamoto S, Yoshikai Y 2004
Jpn Pharmacol Ther
2004;32(7):421-7.
Study Title
Study Summary
Assessment of Safety and
Efficacy of MSM on Bone
and Knee Joints in OA
Animal Model
This study evaluated cartilage formation in growing rats and
cartilage degradation in mice, both are acceptable Human OA
models at recommended human dosage of 0.6g/kg BW/day and
at 10x & 100X. Intake of MSM for 4 wks did not affect cartilage
formation in rat’s knee joints. MSM Intake for 13 weeks decreased
degeneration of the cartilage on knee joint surface of the mice.
100X dosage significantly decreased organ wt. compared to control.
Suppressive effect of
methylsulfonylmethane
(MSM) on type II collageninduced arthritis in DBA/1J
mice
Oral administration of OptiMSM® modified immune responses in
DBA/1J mice. Arthritic deformation and swelling induced by type
II collagen injections (an animal model of rheumatoid arthritis)
were significantly diminished in mice drinking MSM compared to
controls. Abnormal white blood cell proliferation in lymph nodes
was also reduced in mice drinking MSM.
Effect of DMSO and MSM
on a Destructive Process
in the Joints of Mice with
Spontaneous Arthritis
Oral administration of DMSO or its main metabolite MSM lessened
the destructive changes in joints of 36 Mrl/Mn/lnr female mice.
Diminished Inflammatory
Joint Disease in MRL/lpr
Mice Ingesting DMSO or
MSM
A 3% solution of either DMSO or MSM was administered in drinking
water, ad libitum for 3 months. Inflammatory reaction of synovial
tissue was found in 95% of control, 82% of DMSO and 71% of MSM.
Pannus formation was significantly reduced in MSM vs. placebo.
Study using
OptiMSM ®
Murav’ev et al. 1991
Patol Fiziol Eksp Ter 1991,
2:37–39
Moore et al. 1985
Proceedings of Fed of
American Soc.
Of Exp Bio 1985, 530: Abstract
692
This paper is intended to provide scientific and educational information only. It is not intended for use to promote or sell any
product. These statements have not been evaluated by the Food and Drug Administration. Consumption of OptiMSM ® is not
intended for use to diagnose, treat, cure or prevent any disease.
OptiMSM ® is manufactured by Bergstrom Nutrition. ©2016 Bergstrom Nutrition. All rights reserved. Ver 1.0 06/15/2016
3
Published Studies on the Efficacy of MSM
(methylsulfonylmethane)
Oxidative Damage Protection Studies
Additional Oxidative
Damage Protection
Studies-Animal
Radwan et al. 2016
J of Biomed and Pharma Res,
2016, 5(3):10-17
Additional Oxidative
Damage Protection
Studies-Animal
Amirshahrokhi, K. et al. 2013
Inflammation. 2013
Oct;36(5):1111-21. doi:
10.1007/s10753-013-9645-8.
Bohlooli et al. 2013
Iran J. of Basic Med Sci, 2013,
16:896-900
Kamel et al. 2013
Arch. Pharm. Res. 2013,
doi:10.1007/s12272-0130110-x
Mohammadi et al. 2012
Adv in Pharma Sci 2012,
doi:10.1155/2012/507278
Study Title
Actions of Taurine,
Methylsulfonylmethane
and Silymarin Against
Acetaminophen-Induced
Neuro- and HepatoToxicity in Rat
Study Title
Study Summary
This study evaluated the effects of pretreatment (14 days)
with either MSM (400mg/kg/day), taurine, or silymarin on
acetaminophen (APAP)-induced liver and brain injury in rats.
MSM pretreatment resulted in significant amelioration, over
control, of APAP-induced changes in liver enzymes AST and ALT;
brain and liver markers of oxidative stress - MDA, GSH, GSSG,
NO, and 8-OHdG; and 2 brain monoamines - norepinephrine, and
serotonin. MSM significantly outperformed taurine and silymarin
pretreatment in liver NO levels and brain 8-OHdG.
Study Summary
Effect of MSM on
Paraquat-Induced Acute
Lung and Liver Injury in
Mice
Mice treated with 500mg/kg/day i.p. for 5 days histological and
biochemical examination of lung and liver tissue. Results showed
a significant reduction in liver and lung tissue damage and a
significant reduction in tissue levels of MDA, MPO and TNF-α. MSM
significantly increased level of SOD, CAT and GSH. Findings suggest
MSM attenuates PQ-induced pulmonary and hepatic oxidative
injury.
Effect of
Methylsulfonylmethane
Pretreatment on
Acetaminophen Induced
Hepatotoxicity in Rats
The study evaluated effect of pretreatment of MSM on
acetaminophen-induced liver injury in rats. Dosage of MSM pretreatment = 100 mg/kg BW for one week. On day 7 rats received
acetaminophen @ 850mg/kg to induce liver injury. Blood serum
levels of AST and ALT measured 24 hrs post dose. Tissue samples of
liver were evaluated for MDA, GSH, SOD and MPO activity. Results
show acetaminophen caused a negative impact on all measured
biological indices and pre-treatment with MSM significantly
attenuated this negative impact.
Hepatoprotective Effect
of MSM Against Carbon
Tetrachloride-Induced
Liver Injury in Rats
Pre-treatment with MSM (400mg/kg) before a single dose of CCl4
(2ml/kg, i.p.) inhibited serum ALT and AST activities, decreased
liver MDA, TNF-α, IL-6 and Bax/Bcl2 ratio compare to CCl4 group.
MSM raised SOD and CAT activity as well as CYP2E1 level in liver
tissues. MSM protects liver from CCl4 injury possibly through its
antioxidant, anti-inflammatory and anti-apoptotic properties.
Protective Effects of
MSM on Hemodynamics
and Oxidative Stress in
Monocrotaline-Induced
Pulmonary Hypertensive
Rats
MSM administered to rats at 100, 200, and 400 mg/kg/day for 10
days before a single dose of 60 mg/kg, IP, MCT. Blood samples
analyzed for CAT, SOD, GPx, GSH and MDA. MSM treatment showed
potential protective antioxidant effects by a significant increase in
antioxidant enzyme activity and associated reducing agents.
This paper is intended to provide scientific and educational information only. It is not intended for use to promote or sell any
product. These statements have not been evaluated by the Food and Drug Administration. Consumption of OptiMSM ® is not
intended for use to diagnose, treat, cure or prevent any disease.
OptiMSM ® is manufactured by Bergstrom Nutrition. ©2016 Bergstrom Nutrition. All rights reserved. Ver 1.0 06/15/2016
4
Published Studies on the Efficacy of MSM
(methylsulfonylmethane)
Amirshahrokhi, K. et al. 2011
Tox and App Pharm 2011, doi
10.1016/j.taap.2011.03.017
DeSilvestro et al. 2008
FASEB J, 2008, 22:445.8
Published abstract and poster
presentation
Effect of MSM on
Experimental Colitis in the
Rat
Colitis induced by intra-colonic instillation of 1 ml of 5% acetic acid.
Rats treated with MSM at 400mg/kg/day orally for 4 days. Colon
evaluated histologically and biochemically. Micro and macroscopic
colonic damage was decreased. MDA, MPO, and IL-1 were
significantly decreased while GSH levels increased. MSM may have a
protective effect in experimental ulcerative colitis.
MSM intake in Mice
Produces Elevated Liver
Glutathione and Partially
Protects against CCl4
-Induced Liver Damage
MSM administration (5 weeks, 80 mg/100 ml drinking water)
produced a statistically significant increase in liver GSH (mean
increase of 78%). A similar effect was not seen in lung or skeletal
muscle. Also, MSM partially inhibited liver injury after injection of
CCl4, which induces liver oxidative stress.
Study using
OptiMSM ®
Allergy/Immune Studies
Allergy/Immune Studies
Godwin, S. et al. 2015
Journal of the International
Society of Sports Nutrition
Study Title
Study Summary
MSM enhances LPSinduced inflammatory
response after exercise.
Supplementation of MSM blunted the increase in systemic levels
of inflammatory cytokines (IL-6 & IL-1ß) immediately after exercise.
However, Ex vivo incubation of blood from various time points with
LPS caused a dramatic increase in inflammatory cytokines after
exercise only in the group treated with MSM. Also, a 2-3 fold increase
in IL-10 was seen only in the MSM group after LPS stimulation despite
lower IL-10 levels before exercise.
Anti-inflammatory effect
of methylsulfonylmethane
(MSM) in mice
3 aspects of anti-inflammatory effects of OptiMSM evaluated: 1)
Skin damage by UV, 2) Skin inflammation by ovalbumin injection
and 3) Itching from histamine. Results: 1) OptiMSM suppressed skin
inflammation from UV light. 2) Mice that consumed 2.5% OptiMSM
in solution suppressed immediate-phase swelling reaction. 3)
Scratching behavior was considerably less in mice following ingestion
of 2.5% MSM solution for 1 week before histamine injections.
Conclusion: Study confirms MSM is an anti-inflammatory agent, and
it mitigates abnormal immune reactions that trigger inflammation.
A Multi-Centered,
Open Label Trial on the
Safety and Efficacy of
Methylsulfonylmethane in
the Treatment of Seasonal
Allergic Rhinitis
50 person study consumed 2600mg/day MSM orally for 30 days.
Clinical respiratory symptoms and energy levels evaluated by
questionnaire at the beginning and @ days 7, 14, 21, and 30.
Immune and inflammatory reactions were also determined by lab
tests. After 1 week, frequency of upper respiratory symptoms were
significantly improved. At 3 weeks, participants also had significant
improvements in lower respiratory symptoms. All respiratory
improvements were maintained through day 30. Energy levels
improved significantly by day 14, and were maintained through day
30. Minimal side effects reported during trial.
Published abstract and
poster presentation
Study using
OptiMSM ®
Hasegawa T, Ueno S,
Kumamoto S 2005
Jpn Pharmacol Ther
2005;33(12):1217–1223
Study using
OptiMSM ®
Barrager E, Veltmann JR,
Schauss AG, Schiller RN 2002
J Altern Complement Med
2002; 8:167–73.
Study using
OptiMSM ®
Toll Free: 888-733-5676, (888-SEEK-MSM)
[email protected]
This paper is intended to provide scientific and educational information only. It is not intended for use to promote or sell any
product. These statements have not been evaluated by the Food and Drug Administration. Consumption of OptiMSM ® is not
intended for use to diagnose, treat, cure or prevent any disease.
OptiMSM ® is manufactured by Bergstrom Nutrition. ©2016 Bergstrom Nutrition. All rights reserved. Ver 1.0 06/15/2016
5

Similar documents

×

Report this document